Exercise against nonsmall-cell lung carcinoma: novel insights

被引：0
|
作者：
Plaza-Florido, Abel [1 ]
Fiuza-Luces, Carmen [2 ]
Lucia, Alejandro [2 ,3 ]
机构：
[1] Univ Calif Irvine, Sch Med, Dept Pediat, Pediat Exercise & Genom Res Ctr, Irvine, CA 92717 USA
[2] Hosp 12 Octubre imas12, Phys Exercise & Pediat Canc Res Grp, Res Inst, Madrid, Spain
[3] Univ Europea Madrid, Fac Med Hlth & Sports, Dept Sport Sci, Madrid, Spain
来源：
TRENDS IN CANCER | 2025年 / 11卷 / 01期
关键词：
D O I：
10.1016/j.trecan.2024.11.006
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
The mechanisms underlying the potential 'anticancer' effects of exercise remain poorly understood. Luo et al. recently identified an exercise-induced, muscle-derived extracellular vesicle (EV)-associated miR, miR-29a-3p, as a key player in the potential benefits of exercise against nonsmall-cell lung carcinoma (NSCLC), including extracellular matrix (ECM) inhibition and improved antitumoral immune responses.
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [41] Cigarette smoking increases copy number alterations in nonsmall-cell lung cancer
    Huang, Yen-Tsung
    Lin, Xihong
    Liu, Yan
    Chirieac, Lucian R.
    McGovern, Ray
    Wain, John
    Heist, Rebecca
    Skaug, Vidar
    Zienolddiny, Shanbeh
    Haugen, Aage
    Su, Li
    Fox, Edward A.
    Wong, Kwok-Kin
    Christiani, David C.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (39) : 16345 - 16350
  • [42] Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells
    Hatami, Elham
    Nagesh, Prashanth K. B.
    Sikander, Mohammed
    Dhasmana, Anupam
    Chauhan, Subhash C.
    Jaggi, Meena
    Yallapu, Murali M.
    ACS OMEGA, 2022, 7 (27): : 23939 - 23949
  • [43] Response to: "Lymph Node Dissection for NonSmall-Cell Lung Cancer at Whose Discretion?"
    Osarogiagbon, Raymond U.
    Ray, Meredith A.
    Faris, Nicholas R.
    Smeltzer, Matthew P.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (05) : E35 - E36
  • [44] Benefits of chemotherapy for quality of life in patients with advanced nonsmall-cell lung cancer
    Paesmans, M
    CURRENT OPINION IN ONCOLOGY, 2002, 14 (04) : 389 - 393
  • [45] Sequential chemotherapy in nonsmall-cell lung cancer - Cisplatin and gematabine followed by docetaxel
    Ceribelli, Anna
    Pino, Maria S.
    Gelibter, Alain J.
    Milella, Michele
    Cecere, Fabiana L.
    Caterino, Mauro
    Facciolo, Francesco
    Mirri, Alessandra
    Cognetti, Francesco
    CANCER, 2007, 109 (04) : 727 - 731
  • [46] Apatinib for advanced nonsmall-cell lung cancer: A retrospective case series analysis
    Yang, Chengxi
    Feng, Wen
    Wu, Di
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2018, 14 (01) : 159 - 162
  • [47] Chemotherapy versus best supportive care for advanced nonsmall-cell lung cancer
    Abang, AM
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (24) : 2980 - 2984
  • [48] Regulation of nonsmall-cell lung cancer stem cell like cells by neurotransmitters and opioid peptides
    Banerjee, Jheelam
    John, Arokya M. S. Papu
    Schuller, Hildegard M.
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (12) : 2815 - 2824
  • [49] Automatic segmentation of the tumor in nonsmall-cell lung cancer by combining coarse and fine segmentation
    Zhang, Fuli
    Wang, Qiusheng
    Fan, Enyu
    Lu, Na
    Chen, Diandian
    Jiang, Huayong
    Wang, Yadi
    MEDICAL PHYSICS, 2023, 50 (06) : 3549 - 3559
  • [50] Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients
    Williams, BA
    Sugimura, H
    Endo, C
    Nichols, FC
    Cassivi, SD
    Allen, MS
    Pairolero, PC
    Deschamps, C
    Yang, P
    ANNALS OF THORACIC SURGERY, 2006, 81 (03): : 1021 - 1027
12345